Euroscreen, Human Genome Sciences, Icos, Boehringer Ingelheim deal

Euroscreen granted Boehringer a non-exclusive license to a patent portfolio covering the development of therapeutics against CC chemokine receptor 5 ( CCR5) for any indication. Euroscreen is the lice...